Arrowstreet Capital
DNLI icon

Arrowstreet Capital’s Denali Therapeutics DNLI Stock Holding History

Arrowstreet Capital’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,725
Closed -$575K – 1356
2022
Q3 		$575K Buy
+18,725
New +$609K ﹤0.01% 1086
2021
Q4 		– Sell
-96,868
Closed -$4.89M – 1497
2021
Q3 		$4.89M Buy
+96,868
New +$5.46M 0.01% 946
2021
Q2 		– Sell
-85,607
Closed -$4.89M – 1960
2021
Q1 		$4.89M Sell
85,607
-44,232
-34% -$2.96M 0.01% 1184
2020
Q4 		$10.9M Buy
129,839
+74,368
+134% +$4.5M 0.02% 848
2020
Q3 		$1.99M Buy
+55,471
New +$1.67M ﹤0.01% 1555
2020
Q1 		– Sell
-33,242
Closed -$579K – 1922
2019
Q4 		$579K Buy
+33,242
New +$553K ﹤0.01% 1469
2019
Q2 		– Sell
-50,333
Closed -$1.17M – 1455
2019
Q1 		$1.17M Buy
+50,333
New +$1.05M ﹤0.01% 1276

Other funds holding DNLI

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return